Key Highlights
- Morgan Stanley elevates Meta to premier position with analyst Brian Nowak issuing Overweight rating
- Target price adjusted from $825 to $775, representing approximately 50% potential gain from current trading levels
- META shares valued at roughly 15x projected 2027 earnings — one standard deviation under its decade-long average
- Morgan Stanley anticipates “MetaClaw” agentic AI platform could drive substantial future expansion
- Anticipated 20% staff reduction may generate $3–$10 billion in annual savings, enhancing earnings per share
Meta Platforms has experienced significant challenges during the opening months of 2026. Shares have declined approximately 20% since January, pressured by worries surrounding AI capital expenditure, advertising market dynamics, and regulatory scrutiny.
Morgan Stanley believes the market correction presents a compelling opportunity.
Analyst Brian Nowak designated Meta as his firm’s premier investment choice on March 30, launching coverage with an Overweight rating. While reducing his target from $825 to $775, the revised figure still represents approximately 50% appreciation potential from present prices.
“Sentiment has reached bottom… The opportunity to purchase META has arrived,” Nowak stated in his research note.
The investment thesis revolves around valuation metrics. Meta currently trades at approximately 15 times Morgan Stanley’s 2027 earnings projection of $36 per share. This multiple represents one standard deviation beneath its historical 10-year average — a threshold crossed just four times during the past decade.
Nowak identified three primary investor anxieties: returns on Meta’s substantial AI infrastructure investments, digital advertising market strength, and escalating regulatory challenges.
He believes market pricing already reflects these concerns.
Regarding advertising, Nowak reported his recent industry research shows “more positive signals compared to twelve months prior.” He modestly reduced ad revenue projections for 2026 and 2027 by roughly 1% as a prudent adjustment, while maintaining the view that current valuation remains compelling with this conservative approach.
The “MetaClaw” Vision
A particularly intriguing element of Morgan Stanley’s analysis involves a prospective agentic AI offering termed “MetaClaw.” This concept merges MetaAI, the Manus agent, and Moltbook platform into what the firm characterizes as a “personal life assistant.”
The envisioned product would manage personalized content delivery, comprehensive shopping experiences through Messenger, and autonomous web navigation — all integrated within Meta’s established application ecosystem.
Nowak highlighted Meta’s 250 million business accounts and its cross-platform presence spanning Facebook, Instagram, WhatsApp, and Messenger as critical assets for enabling agentic commerce capabilities.
Workforce Optimization Strengthens Investment Case
Industry reports indicate Meta may trim its employee base by approximately 20%. Morgan Stanley calculates this restructuring could yield between $3 billion and $10 billion in annual cost savings, potentially contributing more than $1 to 2027 earnings per share.
“This move would create a more robust ’27 EPS foundation amid ongoing investment,” Nowak explained.
Concerning regulatory matters, recent legal settlements totaling around $380 million appear manageable given Meta’s financial scale. Any comprehensive legislative developments are anticipated to require years before resolution.
Examining the broader analyst community, META commands a Strong Buy consensus derived from 40 Buy ratings, five Hold recommendations, and zero Sell opinions collected over the past three months. The consensus price target among analysts stands at $865.58, suggesting over 64% appreciation potential from present levels.
Morgan Stanley identified May and September as promising near-term catalyst periods, coinciding with Meta’s LlamaCon developer conference and its annual Connect gathering.
